| 000 | 01357 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250515071423.0 | ||
| 264 | 0 | _c20070703 | |
| 008 | 200707s 0 0 eng d | ||
| 022 | _a0277-0008 | ||
| 024 | 7 |
_a10.1592/phco.27.6.888 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVourvahis, Manoli | |
| 245 | 0 | 0 |
_aMechanisms of pharmacokinetic and pharmacodynamic drug interactions associated with ritonavir-enhanced tipranavir. _h[electronic resource] |
| 260 |
_bPharmacotherapy _cJun 2007 |
||
| 300 |
_a888-909 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xdrug effects |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xdrug effects |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV Protease Inhibitors _xpharmacokinetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPyridines _xpharmacokinetics |
| 650 | 0 | 4 |
_aPyrones _xpharmacokinetics |
| 650 | 0 | 4 |
_aRitonavir _xpharmacokinetics |
| 650 | 0 | 4 | _aSulfonamides |
| 700 | 1 | _aKashuba, Angela D M | |
| 773 | 0 |
_tPharmacotherapy _gvol. 27 _gno. 6 _gp. 888-909 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1592/phco.27.6.888 _zAvailable from publisher's website |
| 999 |
_c17082415 _d17082415 |
||